EGFR and cancer: Genes in trend (ii) are involved in heterogeneous pathways, including immune responses (chemokine signaling and cytosolic DNA-sensing pathways), cell shape and motility (focal adhesion and regulation of the actin cytoskeleton), cancer development (proteoglycans in cancer and the ErbB signaling pathway), and viral infections.